The defective CYP21A2 1 (cytochrome P450, family 21, subfamily A, polypeptide 2) genes downstream of the TNXB (tenascin XB) gene in congenital adrenal hyperplasia (CAH) 2 fall into 3 categories: (a) small-scale conversions from the CYP21A1P (cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene) gene, (b) spontaneous mutations, and (c) chimeric RCCX modules that include the chimeric CYP21A1P/CYP21A2 genes and chimeric genes of TNXA [tenascin XA (pseudogene)] and TNXB (1 ) . Most of the CYP21A2 mutations of the 15 loci identified thus far are due to small-scale conversions from CYP21A1P during both meiosis and mitosis (2 ) . These mutations account for approximately 70% to 80% of CAH cases. These 15 mutational loci include nucleotide (nt) Ϫ126 (CϾT), nt Ϫ113 (GϾA), nt Ϫ110 (TϾC), nt Ϫ103 (AϾG), P30L, nt 655 (A/CϾG), nt 707-714del, I172N, cluster E6, V281L, F306⌳L307insT, Q318X, and R356W. The chimeric CYP21A1P/ CYP21A2 and TNXA/TNXB genes, which are caused by unequal crossing over (or deletions) during meiosis (2 ) and occur in approximately 20% of CAH alleles in most populations (1, 3 ) I read with interest the recent report by Chen et al. (4 ) , in which the authors described an analysis of the CYP21A1P/CYP21A2 chimeric gene with a 3.2-kb TaqI-produced fragment prepared from the amplicon amplified with the primer pair CYP779 and Tena32F (5 ). Chen et al. found 2 novel phenotypes of the chimeras, which they termed "CH-8" and "CH-9." According to the authors, CH-8 (Table 1) carried the 15 mutational loci in the defective CYP21A2 gene, but they obtained no data from an analysis of the 3Ј end, owing to a lack of variants to distinguish between CYP21A2 genes (4 ). A report of a prior study by Lee et 
